CDAC Trademark

Trademark Overview

On Monday, November 8, 2021, a trademark application was filed for CDAC with the United States Patent and Trademark Office. The USPTO has given the CDAC trademark a serial number of 97113410. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Wednesday, August 28, 2024. This trademark is owned by BeiGene, Ltd.. The CDAC trademark is filed in the Pharmaceutical Products category with the following description:

Medicines, pharmaceutical preparations, chemico-pharmaceutical preparations, biological preparations for medical purposes, chemical preparations for medical purposes, all of the foregoing for the treatment of cancer and rheumatoid arthritis; diagnostic biomarker reagents for medical purposes; pharmaceuticals for the treatment of cancer, autoimmune and inflammatory diseases and infectious diseases
cdac

General Information

Serial Number97113410
Word MarkCDAC
Filing DateMonday, November 8, 2021
Status733 - FOURTH EXTENSION - GRANTED
Status DateWednesday, August 28, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 30, 2022

Trademark Statements

Goods and ServicesMedicines, pharmaceutical preparations, chemico-pharmaceutical preparations, biological preparations for medical purposes, chemical preparations for medical purposes, all of the foregoing for the treatment of cancer and rheumatoid arthritis; diagnostic biomarker reagents for medical purposes; pharmaceuticals for the treatment of cancer, autoimmune and inflammatory diseases and infectious diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, November 16, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBeiGene, Ltd.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressSan Mateo, CA 94404
Party NameBeiGene, Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGrand Cayman KYI-1108
KY

Trademark Events

Event DateEvent Description
Thursday, November 11, 2021NEW APPLICATION ENTERED
Tuesday, November 16, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, March 22, 2022ASSIGNED TO EXAMINER
Friday, March 25, 2022SUSPENSION LETTER WRITTEN
Friday, March 25, 2022LETTER OF SUSPENSION E-MAILED
Friday, March 25, 2022NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, June 28, 2022TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Thursday, July 14, 2022ASSIGNED TO LIE
Thursday, July 14, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, July 14, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, July 27, 2022ASSIGNED TO EXAMINER
Wednesday, July 27, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 10, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 30, 2022PUBLISHED FOR OPPOSITION
Tuesday, August 30, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 25, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, December 8, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, December 8, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, December 8, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, December 8, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, December 8, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, February 28, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, February 28, 2023SOU EXTENSION 1 FILED
Tuesday, February 28, 2023SOU EXTENSION 1 GRANTED
Thursday, March 2, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 5, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, September 5, 2023SOU EXTENSION 2 FILED
Tuesday, September 5, 2023SOU EXTENSION 2 GRANTED
Thursday, September 7, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 26, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, March 26, 2024SOU EXTENSION 3 GRANTED
Tuesday, March 26, 2024SOU EXTENSION 3 FILED
Wednesday, March 27, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 28, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, August 28, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 28, 2024SOU EXTENSION 4 FILED
Wednesday, August 28, 2024SOU EXTENSION 4 GRANTED

Related Keywords

cdac preparations purposes medical diseases treatment cancer pharmaceutical pharmaceuticals reagents autoimmune